APAL Grand Rounds Series: Perinatal Cannabis Use
Blunt Truths: Debunking Myths about Cannabis in the Perinatal and Postpartum Period
Friday, 2/21/2025, 12:00pm to 1:00pm
Please join us via Zoom or streaming link.
Luke Peterson, DO
Dr. Peterson will be discussing Perinatal Cannabis Use. Presentation tile: Blunt Truths: Debunking Myths about Cannabis in the Perinatal and Postpartum Period.
Learning Objectives:
Review risks of cannabis use in the perinatal and postpartum period
Provide anticipatory guidance for patients using cannabis while breastfeeding
Discuss biopsychosocial treatment for patients with cannabis use disorder
The educational objective for the APAL Grand Rounds Series is to improve medical providers’ knowledge and skills in diagnosing, treating, and supporting pregnant and postpartum individuals experiencing mental health challenges. The APAL Grand Rounds Series is held monthly on a Friday from 12 to 1pm.
Persons with a disability may request a reasonable accommodation, such as a sign language interpreter, by contacting us at 520-626-2725. Requests should be made as early as possible to allow time to arrange the accommodation.
Accreditation Statement:
The University of Arizona College of Medicine - Tucson is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The University of Arizona College of Medicine - Tucson designates this Live Activity for a maximum of 1.00 AMA PRA Category 1 Credit(s)ä. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Relevant Financial Relationships Statement(s):
University of Arizona College of Medicine - Tucson Office of Continuing Medical Education adheres to the ACCME's Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a CME activity, including faculty, planners, reviewers or others are required to disclose all financial relationships with ineligible entities (commercial interests). The CME office reviewers have nothing to disclose. All relevant financial relationships have been mitigated prior to the commencement of the activity.
| Name of individual | Individual's role in activity | Nature of Relationship(s) / Name of Ineligible Company(s) |
| Christopher Luke Peterson, DO | Faculty | Nothing to disclose - 02/03/2025 |
| Kathryn Emerick, MD | Co-Director | Nothing to disclose - 10/07/2024 |
| Saira Kalia, MD | Activity Director | Nothing to disclose - 10/25/2024 |
| Ana Ramos, BA | Activity Coordinator | Nothing to disclose - 10/24/2024 |